Loading clinical trials...
Loading clinical trials...
A Phase Ib Clinical Study of BBI608 for Adult Patients With Advanced, Refractory Hematologic Malignancies
Conditions
Interventions
BBI608
Dexamethasone
+3 more
Locations
8
United States
Rocky Mountain Cancer Centers
Denver, Colorado, United States
Indiana University
Indianapolis, Indiana, United States
West Clinic
Germantown, Tennessee, United States
Cancer Care Centers of South Texas
San Antonio, Texas, United States
Cancer Care Centers of South Texas - HOAST
San Antonio, Texas, United States
Virginia Cancer Specialists, P.C.
Fairfax, Virginia, United States
Start Date
May 1, 2015
Primary Completion Date
December 14, 2018
Completion Date
May 16, 2019
Last Updated
November 14, 2023
NCT05529069
NCT07257419
NCT07203534
NCT07052370
NCT04707300
NCT05779605
Lead Sponsor
Sumitomo Pharma America, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions